Brown Advisory’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $835K | Hold |
90,000
| – | – | ﹤0.01% | 852 |
|
|
2025
Q1 | $660K | Hold |
90,000
| – | – | ﹤0.01% | 903 |
|
|
2024
Q4 | $769K | Hold |
90,000
| – | – | ﹤0.01% | 881 |
|
|
2024
Q3 | $783K | Hold |
90,000
| – | – | ﹤0.01% | 849 |
|
|
2024
Q2 | $616K | Hold |
90,000
| – | – | ﹤0.01% | 896 |
|
|
2024
Q1 | $819K | Hold |
90,000
| – | – | ﹤0.01% | 827 |
|
|
2023
Q4 | $401K | Hold |
90,000
| – | – | ﹤0.01% | 982 |
|
|
2023
Q3 | $283K | Hold |
90,000
| – | – | ﹤0.01% | 1029 |
|
|
2023
Q2 | $464K | Hold |
90,000
| – | – | ﹤0.01% | 926 |
|
|
2023
Q1 | $474K | Hold |
90,000
| – | – | ﹤0.01% | 923 |
|
|
2022
Q4 | $253K | Hold |
90,000
| – | – | ﹤0.01% | 1058 |
|
|
2022
Q3 | $373K | Hold |
90,000
| – | – | ﹤0.01% | 924 |
|
|
2022
Q2 | $362K | Hold |
90,000
| – | – | ﹤0.01% | 916 |
|
|
2022
Q1 | $445K | Hold |
90,000
| – | – | ﹤0.01% | 884 |
|
|
2021
Q4 | $627K | Hold |
90,000
| – | – | ﹤0.01% | 829 |
|
|
2021
Q3 | $900K | Hold |
90,000
| – | – | ﹤0.01% | 713 |
|
|
2021
Q2 | $1.28M | Hold |
90,000
| – | – | ﹤0.01% | 649 |
|
|
2021
Q1 | $1.48M | Buy |
+90,000
| New | +$1.48M | ﹤0.01% | 636 |
|